Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

Helicobacter pylori infection in rheumatic diseases

Authors: Hongyan Wen, Jing Luo, Junxia Li, Xiaofeng Li

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Due to a number of factors, Helicobacter pylori (Hp) infection is increasingly recognized as highly prevalent in many populations and of increasing health concern. Hp infection has been associated with digestive diseases and rheumatic diseases[1]. It remains unclear whether all or part patients of rheumatic diseases should be routinely screened for Hp infection. We have examined predictors of Hp infection in rheumatic diseases so as to define who might benefit most from screening. …
Literature
1.
Yamanishi S, Iizumi T, Watanabe E, et al: Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun. 2006, 74 (1): 248-56. 10.1128/IAI.74.1.248-256.2006.PubMedCentralCrossRefPubMed
Metadata
Title
Helicobacter pylori infection in rheumatic diseases
Authors
Hongyan Wen
Jing Luo
Junxia Li
Xiaofeng Li
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3675

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Poster presentation

Th17 is involved in the pathogenesis of Bechet's disease via CCL20-CCR6 axis

Poster presentation

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis

Poster presentation

Average findings of uric acid in blood in patients with gout with different categories of hyperglycemia

Poster presentation

A novel role for monosodium urate monohydrate crystals and gouty synovial fluids in monocyte migration in gout

Poster presentation

Effect of B cell depletion using peptide tetramers in collagen-induced arthritis

Poster presentation

Risk factors for latent tuberculosis infection in RA patients treated with anti-tumor necrosis factor
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits